The largest database of trusted experimental protocols

2 protocols using rpmi medium

1

Activated Primary T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assays with human primary T cells were conducted by Pharmaron. Human peripheral blood mononuclear cells for these assays were sourced commercially from Sailybio (Cat. No. SLB-HP200A), with ethical approvals and informed consent for the collection. Human primary T cells were isolated from fresh peripheral blood mononuclear cells (Sailybio) using the human Pan T Cell Isolation Kit (Miltenyi Biotec) and resuspended in RPMI medium 1640 containing 10% FBS, 1% penicillin/streptomycin, and 10 ng/mL human IL-2 (R&D Systems). Mouse primary T cells were isolated from fresh spleen cells using the mouse Pan T Cell Isolation Kit (Miltenyi Biotec) and resuspended in RPMI medium 1640 containing 10% FBS, 1% penicillin/streptomycin, and 10 ng/mL mouse IL-2 (R&D Systems). Compounds R80 and T35 were added as appropriate to various concentrations. Cells were seeded into 96-well plates and incubated at 37 °C and 5% CO2 for 1 h. Human or mouse anti-CD3/anti-CD28 Dynabeads (Thermo Fisher Scientific) (78 (link)) and 100 μM cytidine (where appropriate) were then added, and cells were incubated at 37 °C and 5% CO2 for 5 d. CTG reagent (Promega) was added to cells and incubated at room temperature for 30 min, after which luminescence was recorded using a Perkin-Elmer Envision microplate reader.
+ Open protocol
+ Expand
2

OT-1 T Cell Adoptive Transfer Against EG7 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
EG7 cells are derived from EL4 cells and express chicken ovalbumin (OVA) as a tumor antigen. MC38 is a solid tumor predominantly composed of immunosuppressive cell types, such as monocytic myeloid-derived suppressor cells (M-MDSCs; ref. 21) . Congenic CD45.1 þ SJL (8-10-week-old) recipient mice were injected subcutaneously with 5 Â 10 5 EG7 cells. CD8 þ T cells were isolated from spleen and lymph nodes (dissociated as described above) of WT OT-1 or Peli1-KO/OT-1 mice using the Magnisort mouse CD8 þ T cell enrichment kit (Thermo Fisher Scientific). Isolated CD8 þ T cells were stimulated with platecoated anti-CD3 (5 mg/mL, eBioscience), soluble anti-CD28 (2 mg/mL, Invitrogen), and OVA257-264 peptide (1 mg/mL, InvivoGen) in RPMI medium supplemented with IL2 (20 ng/mL, R&D Systems) for 48 hours. 5 Â 10 6 WT OT-1 or Peli1-KO OT-1 cells were intravenously transferred into tumor-bearing mice 10 days after tumor cell injection. Tumors were monitored for 23 days postinoculation, and mice were sacrificed on day 23 to collect draining lymph nodes (DLN) and TILs. Tumor size was determined by caliper measurements 3 times a week.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!